unknown
Stage
1
Investors
About
Vysioneer develops AI-powered tools to analyze tumor heterogeneity in oncology trials, enabling earlier and more precise assessment of treatment efficacy using lesion-level biomarker data.
Explore Vysioneer's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.